A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
Clinical trial NCT07445971 · RECRUITING
Trial details
- NCT number
- NCT07445971
- Sponsor
- ModeX Therapeutics, An OPKO Health Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-24
- Primary completion
- 2027-09-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.